Factor IX gene therapy (Avigen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor IX gene therapy (Avigen)

Drug Alias NameCoagulin BHaemophilia B gene therapy

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionBlood coagulation pathway activationCoagulation factor IX modulatorsFactor IX gene transference

TargetsCoagulation factor IX

Therapy Area/IndicationsHemophilia B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAvigen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAvigen Inc

Active IndicationsN/A

Inactive IndicationsHemophilia B

ATC CodeN/A